TGRN.F Stock Overview
Manufactures and sells Chinese medicine products in Mainland China and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.69 |
52 Week High | HK$0.86 |
52 Week Low | HK$0.69 |
Beta | 0.99 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.98% |
Recent News & Updates
Recent updates
Shareholder Returns
TGRN.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -0.3% | 0.07% |
1Y | n/a | 17.1% | 20.7% |
Return vs Industry: Insufficient data to determine how TGRN.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how TGRN.F performed against the US Market.
Price Volatility
TGRN.F volatility | |
---|---|
TGRN.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.9% |
Market Average Movement | 5.7% |
10% most volatile stocks in US Market | 15.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: TGRN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TGRN.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1669 | 4,101 | Jia Fu Chen | www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
TGRN.F fundamental statistics | |
---|---|
Market cap | US$826.63m |
Earnings (TTM) | US$81.21m |
Revenue (TTM) | US$932.03m |
10.2x
P/E Ratio0.9x
P/S RatioIs TGRN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TGRN.F income statement (TTM) | |
---|---|
Revenue | CN¥6.77b |
Cost of Revenue | CN¥3.93b |
Gross Profit | CN¥2.85b |
Other Expenses | CN¥2.26b |
Earnings | CN¥590.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.46 |
Gross Margin | 42.04% |
Net Profit Margin | 8.71% |
Debt/Equity Ratio | 15.1% |
How did TGRN.F perform over the long term?
See historical performance and comparison